Colgate Palmolive vs PROCTER & GAMBLE (CL vs PG)
Side by side from their SEC filings: revenue, margins, growth, returns and valuation, plus short interest, insider activity and institutional ownership.
PROCTER & GAMBLE is the larger company by revenue ($84.3B vs $20.4B) and market value ($345.5B vs $73.8B). Colgate Palmolive has grown revenue faster over the last 4 fiscal years (+17.0% cumulative vs +10.7%). PROCTER & GAMBLE runs the higher operating margin (24.3% vs 16.2%). PROCTER & GAMBLE trades at the lower trailing P/E (21.7x vs 35.8x).
About Colgate Palmolive
Colgate-Palmolive Company produces and sells oral, personal, and home care products as well as pet nutrition products. Its oral care segment includes toothpaste, toothbrushes, and mouthwashes sold under brands like Colgate and elmex, while personal care products include soaps, deodorants, and skin health items under brands such as Palmolive and Softsoap. The pet nutrition segment offers specialty pet foods for dogs and cats marketed under brands like Hill’s Science Diet and Prescription Diet.
About PROCTER & GAMBLE
Procter & Gamble Company is a multinational consumer goods company that creates, manufactures, markets, and distributes a wide range of daily-use branded products. Its products are sold in about 180 countries through various channels including retail stores, e-commerce, and direct-to-consumer platforms. The company serves customers such as mass merchandisers, grocery stores, drug stores, and specialty retailers, with a focus on product performance, packaging, brand communication, retail execution, and value.
Head to head (CL FY2025 vs PG FY2025)
| Metric | CLFY2025 | PGFY2025 |
|---|---|---|
| Revenue | $20.38B | $84.28B |
| Revenue growth (YoY) | 1.4% | 0.3% |
| Gross margin | 60.1% | 51.2% |
| Operating margin | 16.2% | 24.3% |
| Net margin | 10.5% | 19.0% |
| Net income | $2.13B | $15.97B |
| Diluted EPS | $2.63 | $6.51 |
| FCF margin | 17.8% | 16.7% |
| ROE | 584.1% | 30.6% |
| Debt / equity | 18.8× | 0.5× |
| Market cap | $73.81B | $345.49B |
| P/E (TTM) | 35.8× | 21.7× |
Fundamentals are from each company’s SEC filings (CL FY2025, PG FY2025). P/E and market cap are derived from recent market prices and update daily.
Five-year trend (as reported)
| Revenue | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| CL | $17.42B | $17.97B | $19.46B | $20.10B | $20.38B |
| PG | $76.12B | $80.19B | $82.01B | $84.04B | $84.28B |
Peer standing
Where each company ranks among the 113 Consumer Staples companies, on the same scale. Each figure is ranked only against peers that report it. Percentiles describe position in the distribution, not a rating.
| Metric | CL | PG |
|---|---|---|
| Gross margin | 60.1%92nd percentile of 97 | 51.2%84th percentile of 97 |
| Operating margin | 16.2%88th percentile of 100 | 24.3%93rd percentile of 100 |
| Net margin | 10.5%80th percentile of 105 | 19.0%92nd percentile of 105 |
| FCF margin | 17.8%93rd percentile of 99 | 16.7%91st percentile of 99 |
| Revenue growth (YoY) | +1.4%42nd percentile of 110 | +0.3%39th percentile of 110 |
| ROE | 584.1%Highest of 98 | 30.6%90th percentile of 98 |
| P/E (TTM) | 35.8×78th percentile of 74 | 21.7×51st percentile of 74 |
| Debt / equity | 18.82×99th percentile of 72 | 0.48×44th percentile of 72 |
| Short interest (days to cover) | 2.86d44th percentile of 112 | 2.24d31st percentile of 112 |
Short interest
| FINRA settlement data | CL | PG |
|---|---|---|
| Shares sold short | 17.5M | 24.0M |
| Change vs prior settlement | -14.6% | -3.3% |
| Days to cover | 2.86 | 2.24 |
| As of settlement | 2026-06-30 | 2026-06-30 |
Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data; republishing or redistributing it is not permitted. Not presented as a percentage of float. No FINRA endorsement of this product is implied.
Insider activity (last 90 days)
| Form 4 open-market activity | CL | PG |
|---|---|---|
| Buys | 0 | — |
| Sells | 2 ($955,045) | — |
Open-market purchases and sales reported on SEC Form 4 (grants, exercises and tax withholding excluded). For context, about 16% of covered companies saw any open-market insider buy in a 90-day window.
Held by the same investors
9 tracked 13F managers hold both Colgate Palmolive and PROCTER & GAMBLE as of their latest quarterly filings: AQR Capital Management, Bridgewater Associates, Citadel Advisors, D. E. Shaw, Dodge & Cox, Gotham Asset Management, Millennium Management, Two Sigma Investments, Yacktman Asset Management. See which superinvestors hold your own portfolio with the smart money checker.
Go deeper
Track CL and PG
Get an alert when either company files something material, see which superinvestors own them, and ask their filings a question with cited answers.
Start monitoring freeIncludes one free filing-grounded research answer. Or check your whole portfolio, no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filings before relying on them. Comparisons are descriptive (higher or lower on a reported figure), not a rating or a recommendation. Informational only. Not investment advice.